Publications by authors named "Ana Lucas Dato"
Article Synopsis
- Strongyloidiasis is a parasitic disease that poses significant risks, especially to individuals with weakened immune systems, and is prevalent among both migrants and the native population in the Mediterranean region.
- A study conducted from 2019 to 2022 assessed various screening methods for the disease among a diverse group of participants, revealing a confirmed infection rate of 8.3%.
- The research found that stool PCR tests were more effective than serological screening alone, which missed a notable percentage of cases, and identified specific risk factors like elevated IgE levels and Latin American origin associated with the disease.
Cytokine profile levels and their relationship with parasitemia and cardiomyopathy in people with Chagas disease in Spain. A prospective observational study.
Parasitol Res
December 2023
Immunoregulatory networks may have a role in controlling parasitemia in the chronic phase of human Chagas disease. The aim was to describe the serum cytokine profile of Trypanosoma cruzi in chronically infected patients and to evaluate its relationship with parasitemia and Chagas cardiomyopathy.This prospective observational study included adult patients with chronic Chagas disease.
View Article and Find Full Text PDFIntroduction: There is negligible evidence on the efficacy of ivermectin for treating COVID-19 pneumonia. This study aimed to assess the efficacy of ivermectin for pre-emptively treating hyperinfection syndrome in order to reduce mortality and the need for respiratory support in patients hospitalized for COVID-19.
Methods: This single-center, observational, retrospective study included patients admitted with COVID-19 pneumonia at Hospital Vega Baja from 23 February 2020 to 14 March 2021.
Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis. Here, we present the protocol of the ImmunoStrong study, a prospective observational study aiming to evaluate the effectiveness and safety of a single-dose ivermectin for treatment of uncomplicated strongyloidiasis in immunosuppressed patients.
View Article and Find Full Text PDFBackground: Strongyloidiasis is a parasitic disease with global prevalence. In Spain, autochthonous cases are concentrated in the Mediterranean basin. We aimed to analyze clinical and epidemiological characteristics of infection in Vega Baja del Segura (Spain), comparing autochthonous versus imported cases.
View Article and Find Full Text PDF